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ABSTRACT Phototransduction starts with the activation of a rhodopsin (respectively, coneopsin) molecule, located in the outer
segment of rod (respectively, cone) photoreceptors. The subsequent ampliﬁcation pathway proceeds via theG-protein transducin
to the activation of phosphodiesterase (PDE), a G-protein coupled effector enzyme. In this article, we study the dynamics of PDE
activation by constructing a Markov model that is based on the underlying chemical reactions including multiple rhodopsin
phosphorylations. We derive explicit equations for the mean and the variance of activated PDE. Our analysis reveals that a low
rhodopsin lifetime variance is neither necessary nor sufﬁcient to achieve reliable PDE activation. The numerical simulations show
that during the rising phase the variability of PDE activation is much lower compared to the recovery phase, and this property
depends crucially on the transducin activation rates. Furthermore, we ﬁnd that the dynamics of the activation process greatly differs
depending on whether rhodopsin or PDE deactivation limits the recovery of the photoresponse. Finally, our simulations for cones
show that only very few PDEs are activated by an excited photopigment, which might explain why in S-cones no single photon
response can be observed.
INTRODUCTION
Phototransduction is a multistep process which starts when a
photon activates a rhodopsin (respectively, coneopsin) mol-
ecule in the outer segment of a rod (respectively, cone) pho-
toreceptor. Upon diffusional encounter on internal disks in
rods and on the surface membrane in cones, the activated
opsin binds successively to many copies of transducin, a
G-protein coupled receptor. Finally, each of the activated
transducin binds to a single phosphodiesterase (PDE) effector
protein (1–6). The set of activated PDE molecules hydrolyze
cGMP, a cytosolic diffusible second messenger, which leads
to the closure of cGMP-gated ion channels and thus to the
photoreceptor hyperpolarization. In rods, physiological stud-
ies have revealed that even the absorptionof a singlephotoncan
be detected (2,7–9), while for cones, many quasisynchronous
absorbed photons (approximately seven) are needed to gen-
erate a signal that overcomes the noisy background (10–12).
Remarkably, in rods also the single photon response time
course is very reproducible (see, e.g., (2)). Despite of major
progresses, it is still a challenging problem to unravel the
precise mechanisms responsible for the accuracy and repro-
ducibility of the single photon response in rods.
A high reliability of the rod single photon response implies
a low variability of the number of activated PDE. This
condition can be achieved by controlling accurately the am-
pliﬁcation process. Several factors are involved in this am-
pliﬁcation, such as the lifetime of activated rhodopsin and the
rates of transducin activation. The chemical reactions that
control the deactivation of rhodopsin depend on rhodopsin
kinase, recoverin, and arrestin (4–6). Recent studies (13–17)
have suggested that the reproducibility of the single photon
response might be due to a low variability in the lifetime of
activated rhodopsin, achieved through rhodopsin deactiva-
tion via multiple phosphorylation steps. However, it is still
unclear how many deactivation steps are necessary to repro-
duce the experimental data. In Field and Rieke (14) it was
suggested that at least 12–14 steps are needed; however, nu-
merical studies based on Monte Carlo simulations have
shown that already seven phosphorylation sites are sufﬁcient
to reproduce experimental data (18,19).
To extract the main principles underlying the variability of
the photoresponse, we present here a stochastic analysis of
PDE activation for both rod and cone photoreceptors. Our
model is based on the well-accepted molecular cascade
leading to the activation of the G-protein. To analyze the PDE
dynamics and the associated ﬂuctuation, we derive equations
for the mean and the variance of activated PDE. Since our
approach allows us to compute the time course of the mean
and the variance of excited PDE, it complements previous
stochastic simulations (18,20,21). We derive analytic ex-
pressions for the mean and the variance of rhodopsin lifetime
and the number of activated PDE, and provide numerical
simulations. Furthermore, we study the inﬂuence of various
parameters such as the number of rhodopsin phosphorylation
sites and phosphorylation and transducin activation rates. We
explore the impact of the rhodopsin lifetime on the accuracy
of PDE activation. We study PDE response for scenarios
representing rods and cones in mice and toads. We show that
during the rising phase, the PDE variability is much lower
compared to the recovery phase. We also analyze the role of
whether rhodopsin or PDE lifetimes limit the recovery of the
photoresponse. Our results show that the variability of the
PDE response depends most signiﬁcantly on the transducin
activation rates. Finally, we present simulations suitable for
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cones. We ﬁnd that in cones only very few PDE molecules
are activated, which conﬁrms an earlier suggestion (22).
THEORY
Model for PDE activation
The transduction process following the absorption of a photon has been well
documented both experimentally and theoretically (for reviews see (1–6)).
The Pugh-Lamb model (1,20,23) was based on the properties of two-di-
mensional random collisions and it predicts accurately the rising phase of the
photoresponse. Based on a Markovian approach and using stochastic sim-
ulations of diffusion and chemical reactions, in Felber et al. (21), the mean
and the variance of the simulated photoresponse were obtained for different
lifetimes of activated rhodopsin. We approximate here the different steps
leading to PDE activation by ﬁrst-order chemical reactions and we neglect
the molecular dynamics due to diffusion. This approximation is justiﬁed by
the large number of molecules and the fast diffusion constant. Thus, the
number of activated molecules resulting from diffusional collisions has the
same temporal law compared to reaction equations.
The well-accepted scenario for PDE activation embodied in our model is
the following (see Table 1 for a guide to the parameters used): After a photon
absorption, a rhodopsin molecule, denoted by R, undergoes a conformational
modiﬁcation and changes from an inactive into an active form R*. R* de-
activation occurs through multiple phosphorylation steps, catalyzed by
rhodopsin kinase (RK), and ﬁnally through arrestin binding (15,24–27). We
take into account that the afﬁnity of R* for transducin, RK, and arrestin are
altered by sequential phosphorylations (18,28). The number of rhodopsin
phosphorylation sites is denoted by Np. After photon absorption, rhodopsin
changes into the activated state n ¼ N. The parameter N equals the total
number of R* deactivation steps, and we assume that it is given byN¼Np1 1
(13) (number of phosphorylation sites 1 arrestin binding). When R* en-
counters RK, with a certain probability a phosphorylation occurs and R*
undergoes a transition from the state n to n – 1, modeled by a state-dependent
phosphorylation rate ln. When R* binds to arrestin, there is a certain prob-
ability that R* becomes deactivated, modeled by a transition rate mn from
the state n to the deactivated state n ¼ 0. In each state n . 0, R* activates
G-proteins transducin (T) with a rate kact(n). While T* can bind to a PDEwith
a rate k3 to form a complex denoted by PDE*, the same complex can be
deactivated with a rate k4. The reciprocal of the rate k4 is the lifetime of PDE*
and depends crucially on the concentration of RGS9 (29–32). We neglect
depletion of transducin and PDE because the amount of activated molecules
is negligibly small compared to the total pool of available transducin and
PDE molecules. The kinetic reactions underlying the model (illustrated in
Fig. 1) are summarized as
R

n /
ln
R

n1
R

n /
mn
R0
R

n1 T /
kactðnÞ
R

n1 T

T
1PDE /
k3
PDE

PDE
 /
k4
PDE
: (1)
The model presented in Eq. 1 is a stripped-down version of a more detailed
model, such as the one presented in Hamer et al. (18). To keep the model
simple and clear, we did not include backward reaction rates. We decided to
focus on conditions that can lead to a minimal PDE* variance and therefore
omitted backward reaction rates, which would certainly increase the vari-
ability of the activation process, as was already noticed in Field and Rieke
(14). However, our analysis can be extended without much effort to include
backward reaction rates and intermediate bound states between R* and RK.
For example, the reactions used to model R* phosphorylation in Eqs. 1a–c in
Hamer et al. (18) can be incorporated by using appropriate backward rates
l1n (n now labels also intermediate states),
R

n %
ln
l
1
n
R

n1 :
In contrast, there is no straightforward method to extend our analysis to
incorporate also intermediate bound states between R* and transducin (for
example, as modeled by the reactions Eqs. 3a–d in (18)). Indeed, as will be
seen later on, our mathematical derivations rely on the assumption that R*
deactivation occurs independently from transducin and PDE activation. In
this case, the analysis of R* deactivation can be decoupled from the analysis
of transducin and PDE activation, which greatly reduces the complexity of
the computations. Such a decoupling is justiﬁed when the lifetime of possible
bound states between R* and transducin is short compared to the lifetime of
the phosphorylation states. Since transducin activation occurs much faster
compared to R* phosphorylation, we assume that under normal conditions R*
deactivation occurs almost independently from transducin and PDE activation.
We now proceed with the analysis of the chemical reactions given in Eq.
1. To describe the state of our model, we introduce three stochastic variables
(N,L,K) that can adopt the values (n, l, k): the phosphorylation state n of R*,
the number l of T*, and k of PDE*. The dynamics of the joint probability
TABLE 1 Parameters used in the model
Symbol Description
R*n Activated rhodopsin in state n
R0 Deactivated rhodopsin
T Transducin
T* Activated transducin
PDE Phosphodiesterase
PDE* Activated PDE
Np Number of rhodopsin phosphorylation sites
ln Phosphorylation rate in state n
mn Arrestin binding rate in state n
kact(n) Transducin activation rate in state n
k3 PDE activation rate
k4 PDE* deactivation rate
Rt Mean/SD ratio of rhodopsin lifetime
RPs Steady-state mean/SD ratio of PDE*
RP(t) Time-dependent mean/SD ratio of PDE*
Pmax Maximum number of PDE*
FIGURE 1 Model for PDE activation. (a) Activated
rhodopsin (R*) can be phosphorylated by rhodopsin kinase
(RK) or deactivated by arrestin binding. The phosphory-
lation rates ln and arrestin binding rates mn depend on the
state n of rhodopsin phosphorylation. Through phosphor-
ylation, R* undergoes a transition from a state n to n – 1.
(b) R* in state n activates transducin with a phosphory-
lation-dependent activation rate kact(n). Activated trans-
ducin (T*) binds to PDE with a rate k3 and forms a
complex denoted by PDE*. PDE* is deactivated through
RGS9 with a deactivation rate k4.
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P(n, l, k, t), that at time t we ﬁnd R* in the state n and l T* and k PDE*
molecules, satisﬁes a Master equation (33,34). To derive this equation, we ﬁrst
determine from the system of chemical reactions displayed in Eq. 1 the tran-
sition matrix W(n, l, kjn9, l9, k9, t) between two states (n, l, k) and (n9, l9, k9),
Wðn; l;kjn9; l9; k9; tÞ ¼ ln9dn;n91dl;l9dk;k9 1mn9dn;0dl;l9dk;k9
1 kactðnÞdn;n9dl;l911dk;k91dn;n9dl;l91dk;k9
1 k3l9dn;n9dl;l91dk;k9111k4k9dn;n9dl;l9dk;k91;
(2)
where dx,y is the Kro¨necker delta. From the general shape of the Master
equation (33,34)
@tPðn; l; k; tjn0; l0; k0; t0Þ
¼ +
n9;l9;k9
Wðn; l; kjn9; l9; k9; tÞPðn9; l9; k9; tjn0; l0; k0; t0Þ
 Pðn; l; k; tjn0; l0; k0; t0Þ +
n9;l9;k9
Wðn9; l9; k9jn; l; k; tÞ;
(3)
we obtain, by inserting Eq. 2 into Eq. 3 (we suppress the initial indices (n0, l0,
k0, t0)),
@
@t
Pðn; l;k; tÞ ¼ ln11Pðn11; l;k; tÞ1dn;0 +
N
n9¼1
mn9Pðn9; l;k; tÞ
1kactðnÞPðn; l1;k; tÞ1
1k3ðl11ÞPðn; l11;k1; tÞ
1k4ðk11ÞPðn; l;k11; tÞ
 ðln1mn1kactðnÞ1k3l1k4kÞPðn; l;k; tÞ;
(4)
where N ¼ Np 1 1. The boundary conditions are
Pðn; l; k; tÞ ¼ 0; if ðn; k; lÞ, 0 or n.N;
kactð0Þ ¼ 0;
l1 ¼ 0;
l0 ¼ m0 ¼ 0:
The conditions l0 ¼ m0 ¼ 0 express that the deactivated state is stable. The
condition l1 ¼ 0 accounts for the fact that in the state n ¼ 1 all sites are
phosphorylated. Immediately after photon absorption, R* is in state n ¼ N
and the number of T* and PDE* are zero. Thus, the initial condition forP(n, l,
k, t) is given by
Pðn; l; k; t ¼ 0Þ ¼ dn;Ndl;0dk;0: (5)
Dynamics of activated rhodopsin
We now analyze the dynamics of R*. In particular, we estimate the mean and
the variance of the duration until R* becomes deactivated by arrestin binding.
We start by computing the probabilityP(n, t) that a R*molecule is in the state
n at time t. Our analysis ends with an estimation of the mean to the standard
deviation (SD) ratio of R* lifetime.
State probability P(n, t)
To describe the dynamics of R*, we sum Eq. 4 over the indices l and k. We
obtain an equation for the probability P(n, t) to ﬁnd R* in the state n at time t,
@
@t
Pðn; tÞ
¼
bNPðN; tÞ n ¼ N
ln11Pðn1 1; tÞ  bnPðn; tÞ 1# n#N  1
+
N
n¼1
mnPðn; tÞ ¼ @t 1 +
N
n¼1
Pðn; tÞ
 
n ¼ 0
;
8>><
>>:
(6)
where bn ¼ ln 1 mn. The initial condition is given by P(n, t ¼ 0) ¼ dn,N.
Using the vector notation with PðtÞ ¼ ðPðN; tÞ; . . . ;Pð1; tÞÞ; we rewrite this
system as
@
@t
PðtÞ ¼ SPðtÞ; (7)
where the matrix S is given by
S ¼
bN
lN bN1
..
.
l2 b1
0
BBB@
1
CCCA: (8)
For pairwise different eigenvalues bn we can diagonalize S and using the
eigenvectors of Swe derive explicit expressions for P(n, t). With the notation
pi ¼ li/bi, P(n, t) is given by
Pðn; tÞ ¼
YN
m¼n11
pm
 !
+
N
i¼n
e
bi tbi
bn
YN
k¼n
k 6¼ i
bk
bk  bi
; 1# n#N:
(9)
Mean and variance of rhodopsin lifetime
To compute the mean and the variance of the random R* lifetime T, we use
the probability PR(t) that R* is still active at time t, given by
PRðtÞ ¼ PrfT. tg ¼ +
N
n¼1
Pðn; tÞ: (10)
A direct computation using P(n, t) from Eq. 9 (and the identities in Eq. 71 and
Eq. 72) yields for the mean and the variance of the R* lifetime
t ¼
Z N
0
PrfT. tgdt ¼ +
N
n¼1
1
bn
YN
k¼n11
pk; (11)
S
2
t ¼
Z N
0
t
2 d
dt
PrfT, tgdt  t2
¼
Z N
0
2t PrfT. tgdt  t2 ¼ 2 +
N
n¼1
+
n
j¼1
1
bn
1
bj
YN
k¼j11
pk  t2:
(12)
Equation 11 for the mean R* lifetime has an intuitive interpretation: it is the
sum of the mean lifetimes in each state n multiplied by the probability to
reach this state before being deactivated by arrestin binding.
Reliability of rhodopsin lifetime
We characterize the reliability of R* lifetime by the ratio of the mean to the
standard deviation, denoted by Rt, which is simply the reciprocal of the
1956 Reingruber and Holcman
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coefﬁcient of variation (CV). If Rt is high (respectively, low), the reliability is
high (respectively, low). By using Eqs. 11 and 12, and following the analysis
in the Appendix, we obtain the following estimate:
Rt ¼ CV1t ¼
tﬃﬃﬃﬃﬃ
S
2
t
q # ﬃﬃﬃﬃNp : (13)
The upper limit for Rt depends only on number of R* deactivation steps N.
Based on very general considerations, this result has already been anticipated
(16,17). However, by using the explicit formulas we can now study the
behavior of Rt as a function of the underlying rates. Indeed, the maximum
value Rt ¼
ﬃﬃﬃﬃ
N
p
is achieved if bn¼ const and pn¼ 1 for all n. The condition
bn¼ const conveys that all deactivation states need to have the same lifetime,
while pn ¼ 1 is fulﬁlled if the arrestin binding rates mn vanish for all n . 1.
Thus, the latter condition states that arrestin only binds when R* is in the state
n ¼ 1 and is therefore fully phosphorylated. This assumption is reasonable,
since nonvanishing arrestin binding rates for n . 1 effectively reduce the
number of deactivation steps and therefore increase the variance.
Mean and variance of the transducin
activation rate
The mean and variance of the transducin activation rate are deﬁned as
kactðtÞ ¼ +
N
n¼1
kactðnÞPðn; tÞ; (14)
S
2
kact
ðtÞ ¼ +
N
n¼1
kactðnÞ2Pðn; tÞ  kactðtÞ2: (15)
In principle, the mean and the variance of the activation rate (and any other
quantity that depends only on the phosphorylation state of R*) can be
computed by using the probabilities P(n, t) given in Eq. 9. However, we will
use an alternative method of calculation that relies on differential equations
and the decomposition of the activation rate (see below). This method does
not require us to explicitly compute P(n, t) and facilitates the derivation of
differential equations for the cross-correlation terms (see Eq. 34). We now
derive a differential equation for kactðtÞ by differentiating Eq. 14 with respect
to time and by using Eq. 7,
d
dt
kactðtÞ ¼ +
n
kactðnÞ@tPðn; tÞ ¼ +
n;m
STm;nkactðnÞPðm; tÞ; (16)
where ST is the transposed matrix of S. To solve this equation, we decom-
pose the vector kact ¼ ðkactðNÞ; . . . ; kactð1ÞÞ into the sum of eigenvectors kðiÞact
of the matrix ST,
kact ¼ +
N
i¼1
kðiÞact; (17)
with
STkðiÞact ¼ bikðiÞact: (18)
By induction, we obtain for the components of the vectors kðiÞact
k
ðiÞ
actðnÞ
¼
+
i
j¼1
kactðjÞð
Yn
m¼j1 1
pmÞbi
bj
Yn
k¼ j
k 6¼ i
bk
bk  bi
; for n $ i
0; for n, i
:
8>><
>>>:
(19)
The differential equation for the mean of kðiÞact is given by
d
dt
kðiÞactðtÞ ¼ +
n;m
STm;nk
ðiÞ
actðnÞPðm; tÞ ¼ bikðiÞactðtÞ: (20)
Using the initial condition that at time t ¼ 0 R* is in the state n ¼ N yields
kactðtÞ ¼ +
N
i¼1
k
ðiÞ
actðtÞ ¼ +
N
i¼1
k
ðiÞ
actðt ¼ 0Þebi t ¼ +
N
i¼1
k
ðiÞ
actðNÞebi t:
(21)
Note that the expression for k
ðiÞ
act(N) provided in Eq. 19 can be veriﬁed by
comparing Eq. 21 with the result for kactðtÞ obtained by inserting Eq. 9 into
Eq. 14.
The variance S
2
kact
ðtÞ is calculated analogously to kactðtÞ by decomposing
the vector k2act ¼ ðkactðNÞ2; . . . ; kactð1Þ2Þ.
Mean and variance of activated transducin
and PDE
The mean and variance of T* and PDE* are deﬁned as
TðtÞ ¼ +
N
n¼0
+
N
l¼0
+
N
k¼0
lPðn; l; k; tÞ; (22)
PðtÞ ¼ +
n;l;k
kPðn; l; k; tÞ: (23)
Differentiating Eqs. 22 and 23 with respect to time and using the Master
equation Eq. 4 yields
d
dt
TðtÞ ¼ k3TðtÞ1 kactðtÞ; (24)
d
dt
PðtÞ ¼ k4PðtÞ1 k3TðtÞ: (25)
The deﬁnitions for the variance and the correlations read
S
2
TðtÞ ¼ +
n;l;k
l
2
Pðn; l; k; tÞ  TðtÞ2; (26)
S
2
PðtÞ ¼ +
n;l;k
k2Pðn; l; k; tÞ  PðtÞ2; (27)
S
2
TPðtÞ ¼ +
n;l;k
lkPðn; l; k; tÞ  TðtÞPðtÞ; (28)
S
2
kactT
ðtÞ ¼ +
n;l;k
kactðnÞlPðn; l; k; tÞ  kactðtÞTðtÞ; (29)
S
2
kactP
ðtÞ ¼ +
n;l;k
kactðnÞkPðn; l; k; tÞ  kactðtÞPðtÞ: (30)
The equations for the time derivatives of +2
T
ðtÞ +2
P
ðtÞ; and +2
TP
ðtÞ are
given by
d
dt
S
2
TðtÞ ¼ 2k3S2TðtÞ1 k3TðtÞ1 2S2kactTðtÞ1 kactðtÞ; (31)
d
dt
S
2
PðtÞ ¼ 2k4S2PðtÞ1 2k3S2TPðtÞ1 k3TðtÞ1 k4PðtÞ; (32)
d
dt
S
2
TPðtÞ ¼ ðk31 k4ÞS2TPðtÞ1 k3S2TðtÞ  k3TðtÞ1S2kactPðtÞ:
(33)
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To close this system of equations we additionally have to derive differential
equations for S2kactTðtÞ and S
2
kactP
ðtÞ: This is done by using the decomposition
of kact given in Eq. 17. We ﬁrst write
S
2
kactT
ðtÞ ¼ +
i
S
2
k
ðiÞ
act
T
ðtÞ; S2kactPðtÞ ¼ +
i
S
2
k
ðiÞ
act
P
ðtÞ: (34)
The time derivatives of S2
k
ðiÞ
actT
ðtÞ and S2
k
ðiÞ
actP
ðtÞ are derived as
d
dt
S
2
k
ðiÞ
act
T
ðtÞ ¼ ðbi1 k3ÞS2kðiÞ
act
T
ðtÞ1S2
k
ðiÞ
act
k
act
ðtÞ; (35)
d
dt
S
2
k
ðiÞ
act
P
ðtÞ ¼ ðbi1 k4ÞS2kðiÞ
act
P
ðtÞ1 k3S2kðiÞ
act
T
ðtÞ: (36)
The correlations between kact and k
ðiÞ
act; deﬁned by
S
2
k
ðiÞ
act
k
act
ðtÞ ¼ +
n
k
ðiÞ
actðnÞkactðnÞPðn; tÞ  kactðtÞkðiÞactðtÞ; (37)
are computed by decomposing the vectors xi ¼ ðkðiÞactðNÞkactðNÞ; ::; kðiÞactð1Þ
kactð1ÞÞ into the sum of eigenvectors DðjÞi of the matrix ST,
xi ¼ +
N
j¼1
DðjÞi ; with S
>DðjÞi ¼ bjDðjÞi : (38)
This yields
S
2
k
ðiÞ
act
k
act
ðtÞ ¼ +
j
DðjÞi ðNÞebj t +
j
kðiÞactðNÞkðjÞactðNÞeðbi1bjÞt:
(39)
In practice, the coefﬁcients D
ðjÞ
i ðNÞ are computed numerically by diagonal-
izing the matrix S>. However, by using Eq. 19, also analytic expressions can
be derived.
Finally, we deﬁne the time-dependent PDE reliability ratio RP(t) as
RPðtÞ ¼ CV1P ðtÞ ¼
PðtÞﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
S
2
PðtÞ
q : (40)
SUMMARY
The explicit expressions for kactðtÞ and S2kðiÞactkactðtÞ allow us
to close the system of differential equations for the vari-
ance of PDE*. This system consists of Eq. 21 and Eqs. 24 and
25 for the mean and Eqs. 31–33, Eqs. 35 and 36, and Eq. 39
for the variances. The simulation results will be obtained by
using this close system of equations.
Mean and variance of the total number of
activated PDE
It is usually assumed that reliable R* deactivation entails
reliable PDE activation (13–16); however, it is worthwhile to
have a closer look at the connection between R* lifetime and
PDE activation. For this we compute the mean and the var-
iance of the total number of PDE* molecules produced
during an single photon response (SPR), obtained by setting
k4 ¼ 0, and compare it to the variance of R* lifetime. For
vanishing PDE* deactivation rate k4, after R* shutoff, a
steady state will be reached that contains all the PDE* mol-
ecules activated during the SPR. In the Appendix we derive
expressions for the steady-state mean and variance of PDE*,
Ps ¼ +
N
n¼1
kactðnÞ
bn
YN
k¼n11
pk; (41)
S
2
Ps
¼ Ps1 +
N
n¼1
+
n
j¼1
kactðnÞ
bn
kactðjÞ
bj
YN
k¼j11
pk  P2s : (42)
These expressions share similarities with the ones obtained
for R* lifetime (Eqs. 11 and 12), since merely 1/bn is replaced
by kact(n)/bn. We deﬁne the steady-state reliability ratio RPs,
which corresponds to the reliability of the total number of
PDE*, as the ratio of the steady-state mean to the SD. The
reliability ratio RPs is the inverse of the coefﬁcient of vari-
ation (CV). In the Appendix we obtain a sharp upper bound
for RPs,
RPs ¼ CV1Ps ¼
Psﬃﬃﬃﬃﬃﬃ
S
2
Ps
q # ﬃﬃﬃﬃNpﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
11
N
Ps
r : (43)
In the case when R* activates many PDE* (Ps  N), the
upper limits for RPs and Rt are both equal to
ﬃﬃﬃﬃ
N
p
. However, it
is interesting to examine whether maximal values for RPs and
Rt can be attained simultaneously. The conditions kact(n)/bn¼
const and pn ¼ 1 are required such that RPs achieves its max-
imum, whereas bn ¼ const and pn ¼ 1 are needed to maxi-
mize Rt. The condition kact(n)/bn ¼ const expresses that,
in each state, the same amounts of PDE* have to be activated,
whereas 1/bn ¼ const requires that each state has the same
lifetime. By adjusting the activation rates kact(n), the condi-
tion kact(n)/bn ¼ const can be achieved even when the rates
bn are very different. In that case, RPs can be maximal while
Rt is far from being maximal. In general, because of the
transducin activation rates, maximal values for RPs and Rt are
not achieved simultaneously, which shows that reliable R*
lifetime is neither necessary nor sufﬁcient to achieve reliable
PDE activation. Only for constant transducin activation rates,
kact(n) ¼ kact, the steady-state results for PDE* are deter-
mined by the mean and variance of R* lifetime,
Ps ¼ kactt; (44)
S
2
Ps
¼ Ps1 k2actS2t: (45)
We shall now discuss some aspects of the reliability ratio RPs,
which contains the variability of all the molecular events
contributing to PDE activation. RPs is closely related to the
coefﬁcient of variation of the area below the PDE* time
response, denoted by CVareaP. In Hamer et al. (18) it was
shown that
CVareaP ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
CV
2
Ps
1
1
Ps
r
¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
R
2
Ps
1
1
Ps
s
: (46)
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It is remarkable that CVareaP depends only on the molecular
details involved in PDE activation and not on the PDE*
deactivation rate k4. Consequently, CVareaP does not depend
on whether PDE* or R* deactivation limits the recovery of
the SPR. For large numbers of activated PDE, it follows that
CVareaP  CVPs: (47)
The coefﬁcient of variation CVarea of the area below the SPR
current was introduced in Field and Rieke (14). It measures
the integrated variability of the SPR: when PDE* dynamics
and the SPR current are related by a scaling relationship, we
have that CVarea  CVareaP (18), which ﬁnally leads to
CVarea  CVPs (for sufﬁciently large Ps). Consequently, the
measured value ofCVarea can be used to obtain a lower bound
of the number of R* deactivation steps (by using Eq. 43).
Indeed, experimental results for mutated mouse rods (13)
show that CVarea behaves approximately like 1=
ﬃﬃﬃﬃ
N
p
; the
limiting behavior of CVPs (this is the case under the assump-
tion that the number of deactivation steps N correlates with
the number of phosphorylation sites Np through N¼Np1 1).
We conclude that CVarea is a close measure of CVPs ; but in
general, it is not for the coefﬁcient of variation of R* lifetime
CVt.
RESULTS
Numerical simulations of PDE dynamics
To study the PDE dynamics (mean and variance), we run
numerical simulations of Eq. 21, Eqs. 24 and 25, Eqs. 31–33,
Eqs. 35 and 36, and Eq. 39. Our aim is to examine the in-
ﬂuence of the various parameters on the dynamics of PDE
activation.
Choice of parameters
It has been well documented that the time course of the single
photon response (SPR) differs substantially between am-
phibian and mammalian rod photoreceptors (13,14,16,
17,35). In mouse rods, the maximum of the SPR amplitude
occurs at ;0.1 s (13,35,36), whereas in toad rods, the max-
imum of the amplitude occurs at ;1.9 s (16,17). Hence, we
decided to run simulations for two different scenarios called
Mouse Rod and Toad Rod (see Table 2). Following recent
results (35), the mouse rod scenario is characterized by a R*
lifetime of 0.080 s and a PDE* deactivation rate of 5 s1.
Unfortunately, as far as we know, similar experimental data
is not available for toad rods. To match the time course of the
toad rod photoresponse, we chose for the toad rod scenario a
R* lifetime of 3 s and a PDE* deactivation rate of 1 s1. Most
important, we chose the toad rod parameters such that, con-
trary to the mouse rod scenario, recovery is limited by R*
lifetime and not by PDE* deactivation. This will allow us to
explore the impact of whether rhodopsin R* or PDE* lifetime
limits the recovery. To compare simulations, we decided to
ﬁx the maximum of the mean number of PDE* Pmax at a
value of 150, as suggested in Leskov et al. (37). It is im-
portant to note that for our purpose this value is not critical,
because other values will result in a simple scaling. Finally,
we chose k3 ¼ 50 s1 for the T*-PDE* binding rate (in
(18,19) the authors use k3 ¼ 200 s1). However, the exact
value for k3 is not very important, as long it is not rate-lim-
iting. Our choice of the parameters is summarized in Table 2.
Motivated by previous studies (18,28), we consider that
transducin activation rates kact(n) decay exponentially with
the number of rhodopsin phosphorylations, that is
kactðn 1Þ ¼ evactkactðnÞ; (48)
where vact is an adjustable parameter. We also assume that
the afﬁnity of rhodopsin kinase for R* decays exponentially
with the number of phosphorylations,
ln1 ¼ evlln; (49)
where vl is also a free parameter.
Since we are interested in conditions leading to the
smallest PDE* variance, we will mostly present simulations
for a simpliﬁed scenario, where the arrestin binding rates mn
vanish unless R* is fully phosphorylated (which is the case
when R* is in the state n ¼ 1). Such a scenario is optimal
to achieve a high R* deactivation reliability. Furthermore,
we choose the arrestin binding rate for n ¼ 1 equal to
m1 ¼ evll2: When vl ¼ vact, this choice ensures that
kact(n)/bn ¼ const and therefore maximizes the reliability
ratio RPs. Moreover, the choice m1 ¼ evll2 adapts the ar-
restin binding rate to the phosphorylation rates. In summary,
the arrestin binding rates will be chosen as
mn ¼ 0 for n$ 2 and m1 ¼ evll2 for n ¼ 1: (50)
Although we made an effort to decrease the number of free
parameters, we still have to specify N, lN, kact(N), vl, and
vact. However, the rates lN and kact(N) are ﬁxed by adjusting
rhodopsin’s lifetime and Pmax: For given values N and vl, lN
is determined by rhodopsin lifetime according to Eq. 11. For
given values N, vl, and vact we determine numerically the
value of kact(N) by ﬁxing Pmax ¼ 150: Thus, the remaining
parameters that have to be speciﬁed are N, vl, and vact.
Impact of the number of phosphorylation sites
Using the theory developed in the previous section, we now
study the impact of the number of R* phosphorylation states
on the PDE* response. Such an analysis is particularly rele-
TABLE 2 Toad rod and mouse rod parameters
Mouse rod scenario Toad rod scenario
PDE activation rate (k3) 50 s
1 50 s1
PDE deactivation rate (k4) 5 s
1 1 s1
Mean rhodopsin lifetime (t) 0.080 s 3 s
Max. value of PðtÞ (Pmax) 150 150
The PDE deactivation rate and rhodopsin lifetime for the mouse rod
scenario are taken from Krispel et al. (35).
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vant, since there are transgenic experiments with reduced
number of rhodopsin phosphorylation sites (13,15). We run
some simulations for the mean and the variance of PDE* for
toad rod parameters and vl¼vact¼ 0.1. The condition vl¼
vact ensures that the ratio kact(n)/bn values are constant and
thus leads to a maximal steady-state reliability RPs (see Eq.
43). This condition has also been used previously for simu-
lating the photoresponse (18,19).
Fig. 2 a shows that during the photoresponse the mean
number of T* is very small. Since each T* binds to only one
PDE, the number of transducin and PDE molecules that be-
come activated are equal. However, unlike PDE*, T* does
not accumulate due to the large rate k3 ¼ 50 s1. Contrary to
the assumption that during the rising phase the ratio of the
number of PDE* to T* is constant (1,3,23), we found by
comparing Fig. 2 awith Fig. 2 b that the time course of PDE*
is not proportional to the time course of T*.
We explore in Fig. 2 c how the PDE variance decreases
with growing number of phosphorylation sites Np (Fig. 2 c).
The maximum and the temporal width of the variance both
decrease by increasing the number of phosphorylation sites.
Additionally, the variance does peak approximately two-
times later than the mean and this feature depends only
slightly on the number of phosphorylation sites, as it can be
observed in Fig. 2 d. For six phosphorylation sites, the sim-
ulations in Fig. 2 d are very similar to experimental record-
ings for the photocurrent presented in Field and Rieke (14).
Fig. 2 e shows the PDE reliability RP(t) as a function of the
normalized mean of PDE*, deﬁned as xðtÞ ¼ PðtÞ=max
ðPðtÞÞ: The value x¼ 1 corresponds to the time to peak of the
mean. We decided to plot the reliability ratio RP(t) as a
function of the normalized mean, since this provides a better
resolution of the rising phase and additionally shows how
RP(t) changes as a function of the number of PDE* mole-
cules. The horizontal lines in Fig. 2 e represent the steady-
state values RPs. Our choice of the parameters implies that RPs
is maximal and approximately equal to
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Np11
p
; see Eq. 43.
It is interesting to note in Fig. 2 e that during the rising phase,
RP(t) reaches values that are much beyond the steady-state
value RPs. This apparent paradox is a consequence of the
activation dynamics and cannot be anticipated from steady-
state considerations.
Finally, in Fig. 2 f we plot the probability PR(t) (given by
Eq. 10) that R* is activated up to time t. With increasing
deactivation steps, R* lifetime becomes less variable and
more concentrated around the mean value t. Moreover, since
the decay rate vl is small, the lifetimes of the states n are very
similar and therefore Rt is very close to the optimal valueﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Np11
p
(data not shown).
Transducin activation rates strongly inﬂuence
the dynamics of PDE activation
To study the impact of the transducin activation and phos-
phorylation rates, we present in Fig. 3 and Fig. 4 simulations
for toad rods, obtained for various decay rates vact and vl.
The number of R* phosphorylation sites is ﬁxed to Np ¼ 6,
which is the value found in mouse rods and many other
species (13,15,28). If R* activity decays only slightly with
subsequent phosphorylations (e.g., vact ; 0.1), the PDE*
variance peaks nearly twice later than the mean (Fig. 3 c) and
the ratio RP(t) at time to peak is much higher than the steady-
state ratio RPs (Fig. 3 d). In contrast, Fig. 4, a–c, illustrates
that the parameter vl, which controls the decay of the
phosphorylation rates, does not affect much the dynamics of
PDE activation, although vl strongly inﬂuences the relia-
bility of R* lifetime (Fig. 4 d). We conclude that the behavior
of the transducin activation rates is more decisive for the
PDE* variance than the variability of R* lifetime.
High activation reliability during the rising phase
We now investigate more closely the time course of the re-
liability ratio RP(t) during the rising phase. The simulations
depicted in Fig. 2 e and Fig. 3 d reveal that during the rising
phase RP(t) reaches a maximum that can be much higher than
the steady-state value RPs. Indeed, this behavior follows from
the fact that initially the variance and the mean are almost
equal (see Eq. 68). As a consequence, as long as the variance
and the mean are close, RP(t) approximately increases like the
square root of the mean and, depending on the number of
PDE*, can reach values that are much beyond the steady-
state limit. At a later time, the variance becomes much larger
than the mean and RP(t) decreases. To show this initial be-
havior of the variance, we plot in Fig. 5 a (respectively, Fig.
5 b) the mean to the variance ratio of PDE* corresponding to
the set of parameters used in Fig. 2 e (respectively, Fig. 3 d).
To achieve a high reliability ratio RP(t) during the rising
phase, it is both necessary that the number of phosphorylation
sites Np is large (Fig. 2 e) and the transducin activation rates
are almost constant (Fig. 3 d). Indeed, the main contributions
to the PDE* variance during the rising phase are due to the
variability of R* lifetime and the variability of the transducin
activation rates. The latter can be reduced by choosing vact
close to zero. Increasing the number of phosphorylation sites
reduces the variability of R* lifetime, especially for small
times. Fig. 2 f shows that by increasing the number of phos-
phorylation sites, a growing initial time-window emerges,
during which it is very unlikely that R* becomes deactivated.
During this period, the variability of R* lifetime is very low,
and in particular much lower than the variability of the whole
R* lifetime.
Impact of whether rhodopsin or PDE deactivation
limits recovery
In Fig. 6 we present simulations for the mouse rod scenario,
where the overall PDE* dynamics is much faster compared to
toad rods. In the mouse rod scenario, PDE* deactivation
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limits the recovery, whereas it is R* shutoff in the toad rod
case. By comparing the mouse rod simulations in Fig. 6 with
the corresponding toad rod simulations in Fig. 3, we conclude
that the dynamics of PDE* activation strongly depends on
whether R* or PDE* lifetime limits recovery. Consequently,
interchanging PDE* and R* lifetime should affect the overall
dynamics, as shown by the simulations in Fig. 7. We now
examine more closely these two opposing scenarios (see dis-
cussion corresponding to Fig. 6 in (18)) where R* deactivation
is much faster than PDE* deactivation and then when it is the
opposite.
When R* lifetime is much shorter than PDE* lifetime, we
can ignore PDE* deactivation during the activation period,
and PDE activation and decay occur as two consecutive
events. It follows that the peak of the mean number of PDE*
occurs at a time when R* becomes deactivated (Fig. 6 a and
Fig. 7 a) and is given by the steady-state value Ps: The PDE*
reliability ratio RP(t) at the time to peak is given by the
steady-state value RPs (see Fig. 6 d and Fig. 7 d). Moreover,
during the recovery phase, RP(t) is largely constant and close
to RPs, which can be understood as follows: Since PDE is ﬁrst
activated and then deactivates, during the recovery phase, the
mean and the variance of PDE* are given by a decay process
with initial values Ps and S
2
Ps
;
PðtÞ ¼ Psek4t
S
2
PðtÞ ¼ S2Pse
2k4t1 Pse
k4tð1 ek4tÞ:
For a timescale smaller than k14 ; we approximate S
2
PðtÞ 
S
2
Ps
e2k4t and thus
FIGURE 2 The simulations show the im-
pact of the number of rhodopsin phospho-
rylation sites for the toad rod scenario
deﬁned in Table 2. The phosphorylation
dependency of the phosphorylation, arrest-
in binding, and transducin activation rates
are given by Eqs. 48–50 with vl ¼ vact ¼
0.1. The rates lN and kact(N) are adapted to
ensure that the rhodopsin lifetime and the
maximum number of activated PDE are
according to Table 2. For Np ¼ (0, 1, 3,
6), lN and kact(N) are (0.33, 0.70, 1.6, 3.2)
s1 and (257, 228, 224, 245) s1.
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RPðtÞ ¼
PðtÞﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
S
2
PðtÞ
q  Psﬃﬃﬃﬃﬃﬃ
S
2
Ps
q ¼ RPs :
The times to peak of the PDE* mean and variance are close
(Fig. 6 c and Fig. 7 c). If we deﬁne the duration of the PDE*
response as the time until all the PDE* molecules become
deactivated, then, for large Ps; the mean duration increases
logarithmically with the number of PDE* as k14 lnðPsÞ:
Using some computations, it can be shown that the CV of
the duration decreases logarithmically with Ps: We conclude
that the duration of the response becomes more and more
reliable with increasing number of PDE*, but the CV of the
duration is not zero (see also (18)).
When R* lifetime is much larger compared to PDE* life-
time, because PDE activation and deactivation occur simul-
taneously, unexpected effects are generated. In that case, the
PDE* reliability at time to peak can be much higher than the
steady-state ratio RPs (Fig. 7 d). However, since the ratio RP(t)
cannot grow faster than
ﬃﬃﬃﬃﬃﬃﬃﬃ
PðtÞ
p
(see Eq. 70), the reliability at
time to peak remains bounded by
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
PðtpeakÞ
p
: Consequently,
the CV of the amplitude cannot become zero (see (18)). Even
for constant R* activity kact, a steady state is reached with
P ¼ kact=k4;S2P ¼ P and thus the CV is given by 1=
ﬃﬃﬃ
P
p
: If R*
deactivation is rate-limiting, the duration of the PDE* re-
sponse is determined by R* lifetime and the CV of the du-
ration is given by CVt in Eq. 13, which can be very different
from CVareaP. Most of the variability is generated during the
recovery phase, which causes the variance to peak much later
than the mean (Fig. 7 c).
Finally, Fig. 7 d reveals that there is a tradeoff between the
reliability during the rising and recovery phase: the higher the
reliability during the rising phase, the lower the reliability
will be during the recovery phase. To analyze this behavior,
we remark that CVareaP is independent of what rate limits
recovery (see Eq. 46) and depends only on the number of
phosphorylation sites. Thus, CVareaP is identical in both
scenarios presented in Fig. 7 d. Now, if R* lifetime limits the
recovery, the PDE* reliability during the rising phase is high,
which implies a low area variability in this phase. Conse-
quently, the reliability of PDE* during the recovery phase has
to decrease (which implies a higher area variability in this
phase) to ensure the overall value for CVareaP.
Inﬂuence of arrestin binding rates
We now examine the impact of linearly and exponentially
increasing arrestin binding rates. In the previous simulations,
we allowed arrestin to bind only when R* was fully phos-
phorylated. For a given number of phosphorylation sites, this
condition is optimal to minimize the variance. However,
experimental results indicate that arrestin already weakly
binds before R* is fully phosphorylated. Biochemical data
(28) suggested that arrestin binds only to phosphorylated
FIGURE 3 The simulations show the im-
pact of the phosphorylation dependency of
the transducin activation rates for the toad
rod scenario deﬁned in Table 2. The be-
havior of the phosphorylation, arrestin
binding, and transducin activation rates
are given by Eqs. 48–50 with vl ¼ 0.1
and Np ¼ 6. For vact ¼ (0.1, 0.3, 0.6) the
rates lN and the kact(N) are given by (3.2,
3.2, 3.2) s1 and (245, 356, 482) s1.
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rhodopsin and the afﬁnity increases linearly with the number
of phosphorylations. Such a linear behavior was used for
photoresponse simulations (18,19). However, experiments
(15) have indicated that R* phosphorylation at three sites is
needed to trigger arrestin binding with high afﬁnity, which
does not imply a gradual increase of the binding afﬁnity. In
addition, data obtained from transgenic mice lacking arrestin
do not favor a gradual increase of the arrestin binding rates.
Finally, there are no speciﬁc reasons to favor a linear decay of
the arrestin binding afﬁnity, while rhodopsin kinase and
transducin afﬁnities show an exponential proﬁle.
To investigate the impact of arrestin binding on PDE*
dynamics, we compare in Fig. 8 three arrestin binding sce-
narios called optimal, exp., and linear, obtained for toad rods
with NP ¼ 6 and vact ¼ vl ¼ 0.1: in the optimal scenario,
arrestin binds only when R* is fully phosphorylated. In the
linear scenario, the arrestin binding rates mn increase linearly
with each phosphorylation step. Finally, in the scenario la-
beled by exp., the arrestin binding rates increase twofold with
every phosphorylation step. To better compare these three
scenarios, we chose the arrestin binding rates such that they
reach the same maximal rate mN ¼ 1.8 s1 when R* is fully
phosphorylated. The simulations in Fig. 8 show that a linear
increase leads to the highest PDE* variance and the lowest
reliability ratio RP(t). This behavior is reasonable, since a
linear increase also strongly affects the states before R* is
fully phosphorylated. With an exponential increase, arrestin
binding rates become predominant when R* is almost fully
FIGURE 4 The simulations show the im-
pact of the phosphorylation dependency of
the rhodopsin phosphorylation rates for the
toad rod scenario deﬁned in Table 2. The
behavior of the phosphorylation, arrestin
binding, and transducin activation rates are
given by Eqs. 48–50 with vact ¼ 0.1 and
Np ¼ 6. For vl ¼ (0.1, 0.3, 0.6), the rates
lN and kact(N) are given by (3.2, 6.8, 26.6) s
1
and (245, 273, 312) s1.
FIGURE 5 Mean/variance ratio of acti-
vated PDE. The simulations are obtained
for the scenarios described in Fig. 2 and
Fig. 3.
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phosphorylated, while they are relatively weak before. By
comparing the simulations in Fig. 8 with the ones in Fig. 2,
we deduce that large arrestin binding rates that come up al-
ready before R* has been fully phosphorylated have a similar
impact to reducing the number of R* deactivation steps. For
example, the curves in Fig. 8 for the linear scenario are similar
to corresponding ones in Fig. 2 for Np¼ 1. We conclude that
for a given number of deactivation steps, linearly increasing
arrestin binding rates are not efﬁcient to achieve a high PDE
activation reliability.
Only a few activated PDE molecules in cones
In cone photoreceptors, several synchronous photons have to
be absorbed (10–12) to detect a signal out of the noise. For
that reason, it is not possible to estimate experimentally the
number of PDE* following a single photopigment excitation.
Furthermore, due to experimental difﬁculties, many funda-
mental chemical constants are still missing for cones. A
modeling approach is thus an unavoidable tool to investigate
PDE activation in cones.
The origin of the background noise differs between L- and
S-cones (12): in L-cones, a large spontaneous photopigment
activation rate (12) constitutes the main source of the noise
and this is a direct obstruction of a single photon detection. In
contrast, the photopigment of S-cones is very stable and the
background noise originates from spontaneous PDE activa-
tion (12,22).
Since spontaneous PDE activation is the main source of
dark noise in rods and S-cones, we would like to investigate
the question of why a single photon response can be observed
in rods, but not in S-cones. A possible answer comes from
biochemical data (38,39), which suggest that an excited
photopigment presumably activates only very few PDE
molecules. Biochemical results for carp cones (39) suggest
that R* phosphorylation is much faster in cones compared to
rods (;50 times faster), which seems to be caused by a higher
rhodopsin kinase concentration and activity. Moreover, ex-
perimental data (39) also imply that the transducin activation
rates are much smaller in cones compared to rods (;25 times
smaller) and PDE deactivation is several times faster in cones
compared to rods. This fast rate can be attributed to the higher
RGS9 concentration (40,41).
To estimate the amount of PDE* molecules following a
photopigment excitation, we have run various simulations.
As expected, we found with no surprise that this amount is a
decreasing function of PDE and R* deactivation (Fig. 9). The
simulations presented in Fig. 9 are obtained by increasing the
PDE* deactivation and R* phosphorylation rates of a toad
rod by factors of 5, 10, and 15 (the parameters and simula-
tions corresponding to the toad rod can be found in Fig. 2 for
Np ¼ 6). We do not alter the transducin activation rates, but
smaller transducin activation rates (as suggested in (39))
would additionally diminish the amount of PDE* in cones.
Fig. 9 a shows that increasing the PDE* deactivation rate k4
from 1 s1 to 15 s1 decreases the amount of PDE* from 150
FIGURE 6 The simulations show the im-
pact of the phosphorylation dependency of
the transducin activation rates for the
mouse rod scenario deﬁned in Table 2.
The behavior of the phosphorylation, ar-
restin binding, and transducin activation
rates are given by Eqs. 48–50 with vl ¼
0.1 s and Np ¼ 6. For vact ¼ (0.1, 0.3, 0.6),
the rates lN and kact(N) are given by (120,
120, 120) s1 and (3821, 6300, 10,242) s1.
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(amount for rod) to;15. Since R* lifetime is not changed by
increasing k4, the recovery of the photoresponse is not af-
fected. In Fig. 9 b, R* deactivation is enhanced. Compared to
Fig. 9 a, this shows that a faster R* deactivation is less ef-
fective in diminishing the number of PDE*molecules. In Fig.
9 b PDE* deactivation becomes rate limiting (k4 ¼ 1 s1)
since R* lifetime is reduced from 3 s to 0.6 s, 0.3 s, and 0.2 s.
Finally, in Fig. 9 c, PDE* and R* deactivation are increased
simultaneously, which additionally reduces the amount of
PDE*.
From our simulations we conclude that in cones, consistent
with biochemical data (39), only very few PDE molecules
are activated by an excited photopigment. This result can
explain that for S-cones, contrary to rods, many synchronous
photon absorptions are needed to produce a signal that over-
comes the noise amplitude generated by spontaneous PDE
activation.
DISCUSSION
We have studied here PDE activation by a single excited
photopigment molecule using a Markov model and obtained
explicit equations for the mean and the variance. This ap-
proach allowed us to investigate in detail the dynamics of
PDE activation, which is indispensable and fundamental for
the understanding of the photoresponse in rods and cones.
Most experimental recordings are about the photocurrent,
and today, unfortunately, there are no direct measurements of
PDE activity, which is the main subject here. A full quanti-
tative analysis of the photocurrent will imply to extend the
model by including diffusible cGMP. Nevertheless, it is
reasonable to assume that the photocurrent time course is
largely determined by the one of activated PDE. In that case,
our results can be connected to the photocurrent in two ways:
ﬁrst, to predict the photocurrent characteristics; and second,
to infer from the observed photocurrent properties some of
the unknown molecular details governing PDE activation.
Accurate rhodopsin deactivation does not
necessarily lead to a reliable PDE activation
In rods the low variability of the photoresponse has been
attributed mainly to the reliability of the lifetime of activated
rhodopsin (13–16). In contrast, we have found that reliable
PDE activation can be achieved even when rhodopsin life-
time is unreliable. To show this result, we estimated the re-
liability ratio Rt (mean to standard deviation (SD)) of
rhodopsin lifetime, and the reliability ratio RPs of the number
of activated PDE during a SPR.We have found that the upper
bound for both RPs and Rt is
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Np11
p
(Np is the number of
rhodopsin phosphorylation sites); however, maximal values
for the ratios RPs and Rt are in general not achieved simul-
taneously. RPs is maximal when all rhodopsin deactivation
states have the same lifetime, whereas RPs becomes maximal
FIGURE 7 The simulations show the
impact of interchanging the lifetimes of ac-
tivated rhodopsin and PDE. The phosphor-
ylation, arrestin binding, and transducin
activation rates are given by Eqs. 48–50
with vl ¼ vact ¼ 0.1, Np ¼ 6, k3 ¼ 50 s1.
For t¼ (0.2, 1) s, the rates lN and kact(N) are
(48.2, 9.6) s1 and (1274, 1067) s1.
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when in each state the same amount of PDE molecules are
activated. Our results suggest that, in general, reliable rho-
dopsin deactivation and reliable PDE activation are not
achieved simultaneously. In the literature, the focus is mainly
on the reliability of rhodopsin deactivation, but one has to
remember that the goal is not to reliably deactivate rhodopsin,
but to reliably activate PDE.
In this work we assumed that each rhodopsin phosphor-
ylation occurs through a single step and we did not investi-
gate the effect of possible intermediate states, which implies
that the number of rhodopsin deactivation states is given by
N ¼ Np 1 1. However, rhodopsin phosphorylation could pro-
ceed through additional intermediate steps (as was assumed
in (18)). In such a case, the number of rhodopsin deactivation
states N will become much larger than Np 1 1, which could
signiﬁcantly alter the variability of rhodopsin lifetime and
activated PDE. In this context it is important to clarify
whether rhodopsin activity in the intermediate states is zero
or not. In Hamer et al. (18), the activity in intermediate states
was assumed to be zero and so PDE activation occurred only
in a much smaller subset of the deactivation states. However,
it is also possible that rhodopsin activity persists in inter-
mediate states, which can lead to a higher PDE activation
reliability. In any case, with intermediate states the connec-
tion between the reliability of rhodopsin lifetime and PDE
activation is less obvious, and it is possible to decouple the
reliability of rhodopsin deactivation from the one of PDE
activation.
High activation reliability during the rising phase
Our analysis revealed that the PDE variability is much
smaller during the rising compared to the recovery phase
(see, for example, Fig. 3). This ﬁnding agrees with similar
observations for the photoresponse current (13,14,16). In
particular, we have shown that during the rising phase the
reliability ratio RP(t) reaches a maximum that can be much
higher than the upper limit
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
NP1 1
p
valid for Rt or RPs. The
rational behind this result is as follows: at the beginning, PDE
variance closely equals the mean and therefore RP(t) rises like
the square-root of the mean. For a large RP(t) maximum it is
equally important that rhodopsin deactivates through many
steps and the transducin activation rates decrease only
slightly (not more than 10–20%) with subsequent phosphor-
ylations (see Fig. 2 e and Fig. 3 d).
Biochemical data (28) indicate that the rhodopsin-trans-
ducin afﬁnity decreases nearly twofold with each phosphor-
ylation step, suggesting a similar decrease for the transducin
activation rates. For the numerical simulations presented in
Hamer et al. (18), the rhodopsin-transducin afﬁnity was
chosen to decrease nearly twofold with each phosphorylation
step, in agreement with Gibson et al. (28). Nonetheless, since
a reaction cascade with high backward reactions rates was
used to model transducin activation, the effective transducin
activation rates decreased much less than twofold. Taking
into account the statement that phosphorylation was re-
sponsible for;66% of the total rhodopsin activity reduction
FIGURE 8 The simulations show the im-
pact of different arrestin binding scenarios
for the toad rod scenario deﬁned in Table 2.
The behavior of the phosphorylation and
transducin activation rates are given by Eqs.
48 and 49 with vl¼ vact¼ 0.1 and Np¼ 6.
In the optimal scenario, arrestin binds only
when rhodopsin is fully phosphorylated and
the rate is given by Eq. 50. In the exp.
scenario, the arrestin binding rates increase
twofold with each phosphorylation step
according to mn ¼ 1.8 s1 e0.7(n–1) for
n , N and mN ¼ 0. In the linear scenario,
the arrestin biding rates increase linearly
according to mn ¼ (N – n) 0.3 s1. The
arrestin binding rates are chosen such that
in each scenario they reach the ﬁnal value
m1¼ 1.8 s1. For the (optimal, exp., linear)
scenarios, the rates lN and kact(N) are
given by (3.2, 2.05, 0.9) s1 and (245, 237,
227) s1.
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(18), we estimated an effective decrease at ;14% with each
phosphorylation step. Moreover, experimental results (27)
indicate that rhodopsin’s activity decreases in mouse rods
through phosphorylation (at six phosphorylation sites) by
;50%, suggesting also subsequent decrease at ;10%. Fi-
nally, it is difﬁcult to imagine that the transducin activation
rates decrease by twofold with every phosphorylation step,
since the activation rate would diminish to a very low value
until rhodopsin is fully phosphorylated. In this case, the ﬁnal
rhodopsin shutoff through arrestin would be somehow ob-
solete and would barely change rhodopsin’s activity, con-
trary to what is found (27).
A high activation reliability at peak time requires
that rhodopsin deactivation limits recovery
The reliability ratio RP(t) at the time to peak depends crucially
on whether rhodopsin or PDE deactivation is rate limiting (as
illustrated in Fig. 7). If rhodopsin lifetime is much shorter
than PDE lifetime, PDE deactivation can be neglected during
the rising phase. In this case, the ratio RP(t) at time to peak
and during the recovery phase is determined by the steady-
state value RPs. Furthermore, since most of the PDE variance
is generated by the activation process, the peak of the PDE
mean and variance occur temporally close. In contrast, when
rhodopsin lifetime is much larger than PDE lifetime, inter-
esting dynamic effects show up. First, the ratioRP(t) at time to
peak is no longer determined by RPs and can reach values that
are much larger than
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Np1 1
p
: Second, much of the PDE
variance is now generated during the recovery phase which
causes the variance to peak much later than the mean.
If the PDE variance determines the variance of the single
photon response current and rhodopsin lifetime limits the
photoresponse recovery, our results explain several experi-
mental ﬁndings about the variance of the single photon re-
sponse (14,16,17). Indeed, the measured coefﬁcient of
variation at the peak of the single photon response current,
denoted by CVamp, is found to be at;0.2 and much less than
the expected value 1=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Np1 1
p
: Such a low value is predicted
by the simulations in Fig. 2 e, where we found a value RP(t) at
;5 at peak time (since we expect that CV1amp;RPðtÞ at peak
time). Furthermore, experiments show that the variance of the
single photon response peaks approximately twice later than
the mean (14,16,17), which is similar to what we have found
for the PDE variance in Fig. 2 d.
In mouse rods, PDE deactivation limits the recovery of the
photoresponse (35). In that case, our analysis and the simu-
lations in Fig. 6 d predict a value forCVamp at;1=
ﬃﬃﬃ
7
p ¼ 0:37
(Np ¼ 6). In contrast, CVamp in mouse rods is found to be
;0.2 (F. Rieke, 2007, personal communication), which is
much too low to be explained by RP(t) at peak time. At this
stage, it is not clear how CVamp can become so small even
when PDE lifetime limits the recovery. One possible expla-
nation can be that the PDE variance is not representative for
FIGURE 9 How to make a cone from a
rod. The simulations show the mean PDE
response for faster PDE and rhodopsin
deactivation. The initial values for the rates
are given in Fig. 2 for Np ¼ 6. In panel a,
the PDE deactivation rate k4 is increased
from the initial value 1 s1 by factors of 5,
10, and 15. In panel b, only the phosphory-
lation rate l7 is increased from the starting
value 3.2 s1 by factors of 5, 10, and 15. As
a consequence, rhodopsin lifetime de-
creases from 3 s to 0.6 s, 0. 3 s, and 0.2 s.
In panel c, k4 and l7 are increased simul-
taneously.
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the current variance, and including the cGMP-pathway might
reveal more.
Number of activated PDE molecules during a
single photon response
The maximum number of PDE molecules that are activated
during the single photon response in rods seems to be an
unresolved issue and indeed, a large discrepancy is found in
the literature. For example, inMakino et al. (42) it was argued
that .100 PDE molecules become activated. The numerical
simulations presented in Hamer et al. (18) lead in average to
220 activated PDEs, and the rates provided in the literature
(3,43,44) suggest a maximum value of ,50. In contrast,
based on noise analysis, it was suggested (45) that at least
2000 PDE molecules have to be active at peak time. Because
of these large uncertainties, we decided to ﬁx the maximum
number of activated PDE at a value of 150. At this stage of
our model, this choice has no important consequences, but it
will become a serious issue for further investigations that
include cGMP dynamics. Since the magnitude of cGMP
hydrolysis depends on the number of activated PDE mole-
cules, this quantitative question will have to be resolved
to predict from molecular details the current of a photo-
response.
A related problem concerns the transducin activation rates.
For amphibian rods, a value at ;150 s1 was reported (37),
while for mammalian rods a rate at;1300 s1 was provided
(46). Because the rod photoresponse time course in mam-
malians is much faster compared to amphibians, this suggests
that the transducin activation rates are regulated to ensure the
activation of a reasonable amount of PDE molecules. For
example, a transducin activation rate at;150 s1 would lead
in mouse rods (where the rhodopsin lifetime seems to be
,0.1 s (35)) to the activation of ,10 PDE.
Only a few PDE molecules are activated by a
excited photopigment in cones
Studying PDE activation in cones faces certain difﬁculties
due to the limited amount of biochemical information
available. However, by using the biochemical results for carp
cones (39) as a guideline, our simulations (Fig. 9) suggest
that only very few (,10) PDE molecules are activated by a
single excited photopigment. This behavior would explain
why in cones many quasisynchronous photon absorptions are
needed to generate a signal that overcomes the background
noise (10–12). In L-cones, the small amount of activated PDE
is not an important issue, since already the large spontaneous
photopigment activation rate (12) impedes the observation of
a single photon absorption. However, in S-cones the photo-
pigment is very stable (12) and, contrary to rods, the ab-
sorption of many photons seems to be necessary to activate
sufﬁcient PDE molecules that overcome the background
noise set by spontaneous PDE activation.
APPENDIX
Mean and variance of the total number of PDE*
For k4 ¼ 0 and after R* shutoff, the number of PDE* reaches a steady-state
value that accounts for all the PDE* activated during the response. Since
every T* converts into a PDE*, the steady-state mean and variance of PDE*
can be obtained by calculating the steady-state values of T* (for k3 ¼ 0). By
setting k3 ¼ 0, integrating Eq. 24 from zero to inﬁnity and using Eq. 21, we
obtain the steady-state mean of T* and PDE* as
Ts ¼ Ps ¼
Z N
0
kactðtÞdt ¼ +
N
i¼1
k
ðiÞ
actðNÞ
bi
: (51)
Inserting the expressions for k
ðiÞ
act(N) in Eq. 19 yields the explicit solution
Ps ¼ +
N
i¼1
k
ðiÞ
actðNÞ
bi
¼ +
N
n¼1
kactðnÞ
bn
YN
k¼n11
pk: (52)
The steady-state variance of PDE* is obtained similarly from Eq. 31,
S
2
Ts
¼ S2Ps ¼ 2
Z N
0
S
2
kactT
ðtÞdt1 Ps: (53)
Using Eq. 34 and Eq. 39, the integral can be evaluated to give
S
2
Ps
¼ Ps1 2+
N
i¼1
+
N
j¼1
D
ðjÞ
i ðNÞ
bibj
 P2s : (54)
By using the formula (which can be derived by induction on N)
+
N
i¼1
+
N
j¼1
D
ðjÞ
i ðNÞ
bibj
¼ +
N
i¼1
+
i
j¼1
kactðiÞ
bi
kactðjÞ
bj
YN
k¼j11
pk; (55)
we ﬁnally get
S
2
Ps
¼ Ps1 2+
N
i¼1
+
i
j¼1
kactðiÞ
bi
kactðjÞ
bj
YN
k¼j11
pk  P2s : (56)
Steady-state reliability ratio RPs
We now derive an upper limit for the steady-state ratio of the mean to the
variance of PDE*, given by
RPs ¼
Psﬃﬃﬃﬃﬃﬃ
S
2
Ps
q # ﬃﬃﬃﬃNpﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
11
N
Ps
r : (57)
To prove Eq. 57, we start from the Eq. 52 and Eq. 56 and introduce xi ¼
kact(i)/bi and ai ¼
QN
k¼i11 pk: In terms of xi and ai, we get
Ps ¼ +
N
i¼1
xiai; (58)
S
2
Ps
¼ Ps  P2s 1 2+
N
i¼1
+
i
j¼1
xixjaj: (59)
Because Eq. 57 is equivalent to NS2Ps  ðP2s 1NPsÞ$ 0; using Eq. 59 we
have to show that
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N 2+
N
i¼1
+
i
j¼1
xixjaj  +
N
i¼1
+
N
j¼1
xixjaiaj
 !
 P2s $ 0: (60)
For ai # 1, we have
2+
N
i¼1
+
i
j¼1
xixjaj  +
N
i¼1
+
N
j¼1
xixjaiaj$ 2+
N
i¼1
+
i
j¼1
xixjaiaj
 +
N
i¼1
+
N
j¼1
xixjaiaj ¼ +
N
i¼1
x2
i
a
2
i :
Finally, using the Cauchy-Schwarz inequality yields
lhs: of Eq: 60$N +
N
i¼1
x
2
i
a
2
i  P2s ¼ N +
N
i¼1
x
2
i
a
2
i  +
N
i¼1
xiai
 2
$ 0;
(61)
which completes the proof.
The upper estimate for the ratio Rt of R* lifetime is derived analogously to
RPs by replacing kact(i) with 1. The result is
Rt ¼ tﬃﬃﬃﬃﬃ
S
2
t
q # ﬃﬃﬃﬃNp : (62)
Explicit expressions for the mean of T* and PDE*
Expressions for the mean of T* and PDE* are derived by integrating Eq. 24
and Eq. 25,
TðtÞ ¼ +
i
kðiÞactðNÞ
e
bi t  ek3t
k3  bi
; (63)
PðtÞ ¼ +
i
k3
kðiÞactðNÞ
k3  bi
ebi t  ek4t
k4  bi
 e
k3t  ek4t
k4  k3
 
: (64)
Small time asymptotic
To derive the small time asymptotic of the mean and the variance of PDE*,
we use a Taylor expansion in Eq. 24 and Eq. 25 that leads to
TðtÞ ¼ kactð0Þt1 oðt2Þ ¼ kactðNÞt1 oðt2Þ; (65)
PðtÞ ¼ 1
2
k3T9ð0Þt21 oðt3Þ ¼ 1
2
k3kactðNÞt21 oðt3Þ; (66)
where kactð0Þ ¼ kactðNÞ:We conclude that for small time, the mean of PDE*
rises like t2, in contrast with the linear asymptotic result proposed in the
literature (1,23), where PDE activation by T* was considered to occur
instantaneously. Using again a Taylor expansion in Eqs. 31–33 and in Eqs.
35 and 36, we ﬁnd the small time asymptotic for the variance of T* and PDE*
as
S
2
TðtÞ ¼ TðtÞ1
1
3
bNkactðNÞ2gNt31 oðt4Þ; (67)
S
2
PðtÞ ¼ PðtÞ1
1
20
k23bNkactðNÞ2gNt51 oðt6Þ; (68)
where bN ¼ lN 1 mN and
gN ¼ 1
kactðN  1Þ
kactðNÞ
 2
: (69)
For small time asymptotic, the variance of T* and PDE* equal the mean.
Since all parameters in Eq. 68 and Eq. 67 are positive, the variance cannot be
smaller than the mean and becomes minimal for gN ¼ 0 (kact(N) ¼ kact(N –
1)). In that case, when R* undergoes a transition from the stateN toN – 1, the
activation rate does not change and therefore does not generate any additional
source of variability. The variance becomes also minimal for bN ¼ 0, that is
when activated rhodopsin is stable. In this case, transducin activation
proceeds as a Poisson process.
We now estimate the small time asymptotic of the reliability ratio RP(t),
deﬁned in Eq. 40. Using Eq. 66 and Eq. 68, we obtain
RPðtÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃ
PðtÞ
q
1 1
20
k3bN kactðNÞgNt31 oðt4Þ
 
: (70)
For small time, RP(t) rises proportional to
ﬃﬃﬃﬃﬃﬃﬃﬃ
PðtÞ
p
; while for larger times, the
second term in Eq. 70 becomes predominant and thus attenuates the rising of
RP(t). Moreover, for gN ¼ 0, the ratio RP(t) in Eq. 70 becomes maximal and
the duration of the rising phase is prolonged.
Mathematical identities
The following identities are true for all N real numbers bk:
+
N
i¼1
YN
k¼1
k 6¼ i
bk
bk  bi
¼ 1; (71)
+
N
j¼1
1
bj
YN
k¼1
k 6¼ j
bk
bk  bj
¼ +
N
j¼1
1
bj
: (72)
These formulas can be derived by induction on the number N.
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